Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial (Q34283745)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial |
scientific article |
Statements
1 reference
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial (English)
1 reference
Konrad Beyreuther
1 reference
Colin L Masters
1 reference
Craig W Ritchie
1 reference
Rudolph E Tanzi
1 reference
Christine Mavros
1 reference
Qiao-Xin Li
1 reference
Darryl Carrington
1 reference
Michel Xilinas
1 reference
Steve Macfarlane
1 reference
Maree Mastwyk
1 reference
Lachlan MacGregor
1 reference
Lyn Kiers
1 reference
Robert Cherny
1 reference
Amanda Tammer
1 reference
David Ames
1 reference
Stephen Davis
1 reference
1 December 2003
1 reference
1 reference
Identifiers
1 reference